Pentamidine is an inhibitor of PRL phosphatases with anticancer activity.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Molecular Cancer Therapeutics

• Publication date

  2002-12-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  PMID 12516958
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sodium Stibogluconate Is a Potent Inhibitor of Protein Tyrosine Phosphatases and Augments Cytokine Responses in Hemopoietic Cell Lines1

  2001influential reference
• Metastasis in colorectal cancer associated with phosphatase expression

  2001cited by this paper
• A Phosphatase Associated with Metastasis of Colorectal Cancer

  2001cited by this paper
• Gastrointestinal stromal tumor workshop.

  2001cited by this paper
• Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia.

  2001cited by this paper
• TYK2 and JAK2 Are Substrates of Protein-tyrosine Phosphatase 1B*

  2001influential reference
• Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling.

  2001influential reference
• The Carboxyl Terminus of the Granulocyte Colony- Stimulating Factor Receptor, Truncated in Patients with Severe Congenital Neutropenia/Acute Myeloid Leukemia, Is Required for SH2-Containing Phosphatase-1 Suppression of Stat Activation1

  2001cited by this paper
• SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells.

  2000cited by this paper
• Endogenous IL‐4 is necessary for effective drug therapy against visceral leishmaniasis

  2000cited by this paper
• PRL-1 PTPase expression is developmentally regulated with tissue-specific patterns in epithelial tissues.

  2000cited by this paper
• Prenylation-dependent Association of Protein-tyrosine Phosphatases PRL-1, -2, and -3 with the Plasma Membrane and the Early Endosome*

  2000cited by this paper
• Interleukin-12 regulates the response to chemotherapy in experimental visceral Leishmaniasis.

  2000cited by this paper
• Roles of Endogenous Gamma Interferon and Macrophage Microbicidal Mechanisms in Host Response to Chemotherapy in Experimental Visceral Leishmaniasis

  2000cited by this paper
• In vitro antimicrobial activity of aromatic diamidines and diimidazolines related to pentamidine.

  1999cited by this paper
• Synthesis and anti-Pneumocystis carinii pneumonia activity of novel dicationic dibenzothiophenes and orally active prodrugs.

  1999cited by this paper
• Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1.

  1998cited by this paper
• Protein–tyrosine phosphatases: Structure, mechanism, and inhibitor discovery

  1998cited by this paper
• SHP-1 phosphatase C-terminus interacts with novel substrates p32/p30 during erythropoietin and interleukin-3 mitogenic responses.

  1998cited by this paper
• The role of tyrosine phosphorylation in cell growth and disease.

  1998cited by this paper
• Sequence-selective binding to DNA of bis(amidinophenoxy)alkanes related to propamidine and pentamidine.

  1997cited by this paper
• Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.

  1997cited by this paper
• Macrophages from motheaten and viable motheaten mutant mice show increased proliferative responses to GM-CSF: detection of potential HCP substrates in GM-CSF signal transduction.

  1997cited by this paper
• Prenylation of oncogenic human PTP(CAAX) protein tyrosine phosphatases.

  1996cited by this paper
• Endogenous interleukin 6 can function as an in vivo growth- stimulatory factor for advanced-stage human melanoma cells.

  1996cited by this paper
• Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1

  1996cited by this paper
• Hematopoietic cell phosphatase associates with erythropoietin (Epo) receptor after Epo-induced receptor tyrosine phosphorylation: identification of potential binding sites.

  1995cited by this paper
• Pentamidine does not interfere with nitrite formation in activated RAW 264.7 macrophages but inhibits constitutive brain nitric oxide synthase.

  1995cited by this paper
• Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals.

  1995cited by this paper
• Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1

  1995cited by this paper
• A 100-kb physical and transcriptional map around the EDH17B2 gene: identification of three novel genes and a pseudogene of a human homologue of the rat PRL-1 tyrosine phosphatase

  1995cited by this paper
• Inhibition of constitutive nitric oxide synthase in the brain by pentamidine, a calmodulin antagonist.

  1995cited by this paper
• Derivation of androgen‐independent human LNCaP prostatic cancer cell sublines: Role of bone stromal cells

  1994cited by this paper
• Inhibition of In Vitro Splicing of a Group I Intron of Pneumocystis carinii

  1994cited by this paper
• PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth

  1994influential reference
• Association of hematopoietic cell phosphatase with c-Kit after stimulation with c-Kit ligand

  1993cited by this paper
• Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB.

  1993cited by this paper
• Treatment of experimental visceral leishmaniasis in a T-cell-deficient host: response to amphotericin B and pentamidine

  1993cited by this paper
• Attenuation of influenza A virus by insertion of a foreign epitope into the neuraminidase

  1992cited by this paper
• Development of Pentamidine Analogues as New Agents for the Treatment of Pneumocystis carinii Pneumonia a

  1990cited by this paper
• Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis.

  1989cited by this paper
• Comparison of tissular disposition of pentamidine mesylate in the rat after aerosol or parenteral administration.

  1989cited by this paper
• Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies.

  1988cited by this paper
• Distribution of pentamidine in patients with AIDS.

  1988cited by this paper
• Comparative properties of five human ovarian adenocarcinoma cell lines.

  1985cited by this paper
• Pentamidine: a review.

  1985cited by this paper
• Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.

  1984cited by this paper
• An in vitro model for investigation of chemotherapeutic agents in leishmaniasis.

  1980cited by this paper
• The experimental chemotherapy of leishmaniasis, IV. The development of a rodent model for visceral infection.

  1980cited by this paper
• Heterotransplantation of a human prostatic adenocarcinoma cell line in nude mice.

  1977cited by this paper
• Classification of human colorectal adenocarcinoma cell lines.

  1976influential reference
• The experimental chemotherapy of leishmaniasis. II. The activity in tissue culture of some antiparasitic and antimicrobial compounds in clinical use.

  1975cited by this paper
• In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.

  1973influential reference

• Repurposing the anti-parasitic agent pentamidine for cancer therapy; a novel approach with promising anti-tumor properties

  2025cites this paper
• The PACT Network: PRL, ARL, CNNM, and TRPM Proteins in Magnesium Transport and Disease

  2025cites this paper
• Targeting PRL phosphatases in hematological malignancies

  2024cites this paper
• In silico identification of putative druggable pockets in PRL3, a significant oncology target

  2024cites this paper
• Binding mechanism of pentamidine derivatives with human serum acute phase protein α1-acid glycoprotein.

  2024cites this paper
• Protein Tyrosine Phosphatase PRL-3: A Key Player in Cancer Signaling

  2024cites this paper
• PRL3 as a therapeutic target for novel cancer immunotherapy in multiple cancer types

  2023cites this paper
• Identification of putative druggable pockets in PRL3, a significant oncology target, using in silico analysis

  2023cites this paper
• Azafuramidines as Potential Anticancer Agents: Pro-apoptotic Profile and Cell Cycle Arrest.

  2023cites this paper
• Therapeutic potential of pentamidine for glioma‐initiating cells and glioma cells through multimodal antitumor effects

  2023cites this paper
• Identification of therapeutically potential targets and their ligands for the treatment of OSCC

  2022cites this paper
• Selective delivery of pentamidine toward cancer cells by self-assembled nanoparticles.

  2022cites this paper
• Phosphatase‐independent role of phosphatase of regenerating liver in cancer progression

  2022cites this paper
• Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway

  2022cites this paper
• Nanotechnological approaches for pentamidine delivery

  2022cites this paper
• Pentamidine Inhibits Ovarian Cancer Cell Proliferation and Migration by Maintaining Stability of PTEN in vitro

  2021cites this paper
• The dual inhibition against the activity and expression of tyrosine phosphatase PRL-3 from a rhodanine derivative.

  2021cites this paper
• Specificity of Molecular Fragments Binding to S100B versus S100A1 as Identified by NMR and Site Identification by Ligand Competitive Saturation (SILCS)

  2021cites this paper
• DDDT_A_311187 2857..2868

  2021cites this paper
• The double lives of phosphatases of regenerating liver: A structural view of their catalytic and noncatalytic activities

  2021cites this paper
• Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment

  2020cites this paper
• Steering the Clinical Translation of Delivery Systems for Drugs and Health Products

  2020cites this paper
• Drug Repositioning for the Treatment of Glioma: Current State and Future Perspective

  2020cites this paper
• Pentamidine niosomes thwart S100B effects in human colon carcinoma biopsies favouring wtp53 rescue

  2020cites this paper
• The role of integrins in melanoma: a review

  2020cites this paper
• Synthesis and Structure Elucidation of New Benzimidazole Amidoxime Derivatives

  2020cites this paper
• Oral pentamidine-loaded poly(d,l-lactic-co-glycolic) acid nanoparticles: an alternative approach for leishmaniasis treatment

  2019cites this paper
• Pentamidine inhibits prostate cancer progression via selectively inducing mitochondrial DNA depletion and dysfunction

  2019cites this paper
• Mechanism of thienopyridone and iminothienopyridinedione inhibition of protein phosphatases.

  2019cites this paper
• Pentamidine-Loaded Lipid and Polymer Nanocarriers as Tunable Anticancer Drug Delivery Systems.

  2019cites this paper
• Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning

  2019cites this paper
• Drug reformulation for a neglected disease. The NANOHAT project to develop a safer more effective sleeping sickness drug

  2019cites this paper
• Steering the Clinical Translation of Delivery Systems for Drugs and Health Products

  2019cites this paper
• Tapping the therapeutic potential of protein tyrosine phosphatase 4A with small molecule inhibitors.

  2019cites this paper
• BOARD 2017-2018

  2018cites this paper
• Rôle de la phosphatase PRL-3 et de CRMP2 dans la migration et l'invasion du mélanome uvéal

  2018influential citation
• Antiproliferative activity of synthesized some new benzimidazole carboxamidines against MCF-7 breast carcinoma cells

  2018cites this paper
• Phosphatases of Regenerating Liver (PRL) as Therapeutic Targets in Cancer

  2018cites this paper
• Targeting phosphatases of regenerating liver (PRLs) in cancer

  2018cites this paper
• Strategies to Obtain Encapsulation and Controlled Release of Pentamidine in Mesoporous Silica Nanoparticles

  2018cites this paper
• Small molecule targeting of PTPs in cancer.

  2017cites this paper
• Critical Roles of Dual-Specificity Phosphatases in Neuronal Proteostasis and Neurological Diseases

  2017cites this paper
• Dual Action Enhancement of Gold Nanoparticle Radiosensitization by Pentamidine in Triple Negative Breast Cancer

  2016cites this paper
• Current status of PTP-based therapeutics

  2016cites this paper
• The PRL PTPs: Regulating Gene Expression to Reprogram the Cancer Cell

  2016cites this paper
• Phosphatases: Their Roles in Cancer and Their Chemical Modulators.

  2016cites this paper
• Molecular modeling, in silico screening and molecular dynamics of PfPRL-PTP of P. falciparum for identification of potential anti-malarials

  2016cites this paper
• Small Molecule Inhibitors of Ca(2+)-S100B Reveal Two Protein Conformations.

  2016cites this paper
• Discovery and Evaluation of PRL Trimer Disruptors for Novel Anticancer Agents.

  2016cites this paper
• Synthesis, antimicrobial, and antiproliferative activities of substituted phenylfuranylnicotinamidines

  2016cites this paper
• Structural Analysis of Protein Tyrosine Phosphatases

  2016influential citation
• S100B-p53 disengagement by pentamidine promotes apoptosis and inhibits cellular migration via aquaporin-4 and metalloproteinase-2 inhibition in C6 glioma cells.

  2015cites this paper
• Phosphatase Inhibitors Function as Novel, Broad Spectrum Botulinum Neurotoxin Antagonists in Mouse and Human Embryonic Stem Cell-Derived Motor Neuron-Based Assays

  2015influential citation
• Análise da participação da oligopeptidase B e triparedoxina peroxidase citoplasmática na virulência de Leishmania (Leishmania) amazonensis.

  2015cites this paper
• Development of a liposome formulation for improved biodistribution and tumor accumulation of pentamidine for oncology applications.

  2015cites this paper
• S 100 Bp 53 disengagement by pentamidine promotes apoptosis and inhibits cellular migration via aquaporin-4 and metalloproteinase-2 inhibition in C 6 glioma cells

  2015cites this paper
• A hyaluronic acid–pentamidine bioconjugate as a macrophage mediated drug targeting delivery system for the treatment of leishmaniasis

  2015cites this paper
• Drug repurposing in the treatment of Melanoma Brain Metastasis

  2015cites this paper
• Computational Repositioning and Preclinical Validation of Pentamidine for Renal Cell Cancer

  2014cites this paper
• Cancer Biology and Signal Transduction Computational Repositioning and Preclinical Validation of Pentamidine for Renal Cell Cancer

  2014cites this paper
• Investigational inhibitors of PTP4A3 phosphatase as antineoplastic agents

  2014cites this paper
• Understanding the biological function of phosphatases of regenerating liver, from biochemistry to physiology

  2014cites this paper
• Phosphatase of regenerating liver in hematopoietic stem cells and hematological malignancies

  2014cites this paper
• Some non-conventional biomolecular targets for diamidines. A short survey.

  2014cites this paper
• Dual-Specificity Phosphatases as Molecular Targets for Inhibition in Human Disease

  2014cites this paper
• Amoebiasis: Neurological Involvement and Neurobiology

  2014cites this paper
• Biochemical evaluation of virtual screening methods reveals a cell-active inhibitor of the cancer-promoting phosphatases of regenerating liver

  2014cites this paper
• Simultaneous inhibition of key growth pathways in melanoma cells and tumor regression by a designed bidentate constrained helical peptide

  2014cites this paper
• Crosstalk between kinases, phosphatases and miRNAs in cancer.

  2014cites this paper
• Targeted deletion of Ptp4a3 inhibits colon carcinogenesis and angiogenesis

  2013cites this paper
• Phosphatomes of Unicellular Eukaryotic Parasites

  2013cites this paper
• Suppression of breast tumor growth by DNA vaccination against phosphatase of regenerating liver 3

  2013cites this paper
• Synthesis and cytotoxic evaluation of novel N-substituted amidino-1-hydroxybenzimidazole derivatives

  2013cites this paper
• Biophysical characterization of the bindng of homologous anthraquinone amides to DNA

  2012cites this paper
• Impact of oncogenic protein tyrosine phosphatases in cancer.

  2012cites this paper
• Targeting mitogen-activated protein kinase phosphatase-1 (MKP-1): structure-based design of MKP-1 inhibitors and upregulators.

  2012cites this paper
• Pentamidine sensitizes chronic myelogenous leukemia K562 cells to TRAIL-induced apoptosis.

  2012influential citation
• Overexpression of phosphatase regenerating liver 3 in oesophageal squamous cell carcinoma associated with metastasis and its comparison with phosphatase regenerating liver 1

  2012cites this paper
• Identification and characterization of novel substrates/ interacting partners for the protein tyrosine phosphatase PRL-2

  2012cites this paper
• Using small molecules to target protein phosphatases.

  2011cites this paper
• Connecting Parkinson's disease and drug addiction: common players reveal unexpected disease connections and novel therapeutic approaches.

  2011cites this paper
• Pentamidine reduces expression of hypoxia-inducible factor-1α in DU145 and MDA-MB-231 cancer cells.

  2011influential citation
• Probing cardiac repolarization reserve in drug safety assessment

  2011cites this paper
• Expression of Phosphatase Regenerating Liver-1 in Esophageal Squamous Cell Carcinoma Associated with Metastasis

  2011cites this paper
• Inhibition of lysosomal degradation rescues pentamidine-mediated decreases of K(IR)2.1 ion channel expression but not that of K(v)11.1.

  2011cites this paper
• Novel pentamidine derivatives: synthesis, anti-tumor properties and polynucleotide-binding activities.

  2011cites this paper
• UNCOVERING THE BIOLOGICAL FUNCTIONS OF PHOSPHATASE OF REGENERATING LIVER -2

  2010cites this paper
• Pharmacological Targeting of the Mitochondrial Phosphatase PTPMT1

  2010cites this paper
• Targeting protein tyrosine phosphatases for anticancer drug discovery.

  2010cites this paper
• The effect of pentamidine on melanoma ex vivo

  2010cites this paper
• PRL-2 increases Epo and IL-3 responses in hematopoietic cells.

  2010cites this paper
• Theoretical models of pentamidine analogs activity based on their DNA minor groove complexes.

  2010cites this paper
• PRL‐3 phosphatase and cancer metastasis

  2010cites this paper
• The effect of pentamidine on melanoma

  2010cites this paper
• Structure-activity study of pentamidine analogues as antiprotozoal agents.

  2009cites this paper
• Role of tyrosine phosphatase inhibitors in cancer treatment with emphasis on SH2 domain-containing tyrosine phosphatases (SHPs).

  2009cites this paper
• The therapeutic potential of phosphatase inhibitors.

  2009cites this paper
• Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer.

  2009cites this paper
• Drug Resistance in African Trypanosomiasis

  2009cites this paper
• Drug discovery and protein tyrosine phosphatases.

  2009cites this paper